Striving for Evidence-Based, Patient-Centered Guidance: The Impetus Behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements

Avital Y. O'Glasser; Kurt J. Pfeifer; Angela F. Edwards; Jeanna D. Blitz; Richard D. Urman

doi:10.1016/j.mayocp.2020.06.022

Striving for Evidence-Based, Patient-Centered Guidance: The Impetus Behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements

Avital Y. O'Glasser
, Kurt J. Pfeifer
, Angela F. Edwards
, Jeanna D. Blitz
, Richard D. Urman

Anesthesiology

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English
Pages (from-to)	1117-1119
Number of pages	3
Journal	Mayo Clinic Proceedings
Volume	96
Issue number	5
DOIs	https://doi.org/10.1016/j.mayocp.2020.06.022
State	Published - May 2021

Access to Document

10.1016/j.mayocp.2020.06.022

Cite this

@article{8972ff5b0d4b4153b16fee5fef73552d,

title = "Striving for Evidence-Based, Patient-Centered Guidance: The Impetus Behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements",

author = "O'Glasser, \{Avital Y.\} and Pfeifer, \{Kurt J.\} and Edwards, \{Angela F.\} and Blitz, \{Jeanna D.\} and Urman, \{Richard D.\}",

note = "Funding Information: Potential Competing Interests: Dr Urman has served on the advisory boards of Heron Therapeutics, Inc; Takeda Pharmaceutical Company Limited; Acacia Pharma Inc; Sandoz International GmbH; Medtonic; and Merck \& Co, Inc, and has received/has grants pending from Medtronic; Merck \& Co, Inc; and AcelRx Pharmaceuticals, Inc. The other authors report no competing interests.",

year = "2021",

month = may,

doi = "10.1016/j.mayocp.2020.06.022",

language = "English",

volume = "96",

pages = "1117--1119",

journal = "Mayo Clinic Proceedings",

issn = "0025-6196",

number = "5",

}

Striving for Evidence-Based, Patient-Centered Guidance: The Impetus Behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements. / O'Glasser, Avital Y.; Pfeifer, Kurt J.; Edwards, Angela F. et al.
In: Mayo Clinic Proceedings, Vol. 96, No. 5, 05.2021, p. 1117-1119.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - Striving for Evidence-Based, Patient-Centered Guidance

T2 - The Impetus Behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements

AU - O'Glasser, Avital Y.

AU - Pfeifer, Kurt J.

AU - Edwards, Angela F.

AU - Blitz, Jeanna D.

AU - Urman, Richard D.

N1 - Funding Information: Potential Competing Interests: Dr Urman has served on the advisory boards of Heron Therapeutics, Inc; Takeda Pharmaceutical Company Limited; Acacia Pharma Inc; Sandoz International GmbH; Medtonic; and Merck & Co, Inc, and has received/has grants pending from Medtronic; Merck & Co, Inc; and AcelRx Pharmaceuticals, Inc. The other authors report no competing interests.

PY - 2021/5

Y1 - 2021/5

UR - https://www.scopus.com/pages/publications/85101211112

U2 - 10.1016/j.mayocp.2020.06.022

DO - 10.1016/j.mayocp.2020.06.022

M3 - Editorial

C2 - 33618849

AN - SCOPUS:85101211112

SN - 0025-6196

VL - 96

SP - 1117

EP - 1119

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

IS - 5

ER -

Striving for Evidence-Based, Patient-Centered Guidance: The Impetus Behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements

Access to Document

Other files and links

Cite this